EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation

Carlos M Soto-Faguás, Abigail O'Niel, Elizabeth Saltonstall, Paul A Mueller, Paula Sanchez-Molina, Lev M Fedorov, Randall L Woltjer, Jacob Raber, Vivek K Unni

Cell Reports · 2026-11 · 45 (11) · 118301

DOI: 10.1016/j.celrep.2026.118301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-11. Verfasst von Carlos M Soto-Faguás und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Oregon Health & Science University, Portland, OR, USA; Jungers Center for Neurosciences Research, Oregon Health & Science Un…. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: American Parkinson Disease Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apolipoprotein E (APOE) genotype alters the risk for Alzheimer's disease (AD) but also affects dementia risk in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Recent evidence suggests that the APOE Christchurch (CC) mutation protects against AD, however, its effects on PD and DLB are unknown. We generated an APOE CC knock-in mouse to understand its effects on amyloid-β (Aβ), tau, and α-synuclein (α-syn) aggregation. APOE CC mice show increased plasma cholesterol and triglyceride levels, decreased Aβ and Aβ-induced tau pathology after intracortical AD-tau injection into 5xFAD mice but do not change Aβ or tau pathology in individual transgenic mouse models without injection. Interestingly, APOE CC reduces formation and spread of α-syn aggregation in the brain, peripheral-to-spinal cord spread, and directly increases binding affinity to α-syn compared to APOE WT. Our study emphasizes the remarkable protective effects of a point mutation in murine APOE against Aβ-induced tau and α-syn aggregation.

Schlagwörter

Stichwörter der Autor:innen

APOEAlzheimer’s diseaseAꞵCP: neuroscienceChristchurchLewy bodiesParkinson's diseasedementia with Lewy bodiesmicetauα-synuclein

Autor:innen und Institutionen

  • Department of Neurology, Oregon Health & Science University, Portland, OR, USA; Jungers Center for Neurosciences Research, Oregon Health & Science University, Portland, OR, USA. Electronic address: sotofagu@ohsu.edu.
  • Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.
  • Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
  • Independent Researcher, Portland, OR, USA.
  • OHSU Transgenic Mouse Models Core Lab, Oregon Health & Science University, Portland, OR, USA.
  • Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA.

Förderung

  • American Parkinson Disease Association

Zitieren

APA

Soto-Faguás, C. M., O'Niel, A., Saltonstall, E., Mueller, P. A., Sanchez-Molina, P., Fedorov, L. M., Woltjer, R. L., Raber, J., & Unni, V. K. (2026). Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation. Cell Reports, 45(11), 118301. https://doi.org/10.1016/j.celrep.2026.118301

Vancouver

Soto-Faguás CM, O'Niel A, Saltonstall E, Mueller PA, Sanchez-Molina P, Fedorov LM, et al. Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation. Cell Reports. 2026;45(11):118301. doi:10.1016/j.celrep.2026.118301

BibTeX
@article{SotoFagus2026,
  author = {Soto-Faguás, Carlos M and O'Niel, Abigail and Saltonstall, Elizabeth and Mueller, Paul A and Sanchez-Molina, Paula and Fedorov, Lev M and Woltjer, Randall L and Raber, Jacob and Unni, Vivek K},
  title = {Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {118301},
  doi = {10.1016/j.celrep.2026.118301}
}
Kostenlos starten →